This review paper on the safety and side effects of cannabidiol by the NCBI, for example, suggests that controlled cannabidiol administration is safe and non-toxic in humans and animals. It also does not induce changes in food intake, nor does it affect physiological parameters like heart rate, body temperature or blood pressure. Also, according to this review paper, “high doses up to 1,500 mg/day of CBD are reportedly well tolerated in humans.”
This is the second time Moon Mother Hemp Company has placed among the top five brands on our ranking. The Colorado-based company, which was founded about a year ago, sets the bar very high for quality (including USDA-certified organic hemp) without charging the moon for its products. Their tinctures taste so good, you may be sad you don’t need more.
Amazon reviews may be few, but each are 5-star and outline excellent experiences in the management of pain and stress. On the company’s website, a plethora of customers site amazing experiences in managing pain. Consumers of Panacea’s F.A.S.T. hemp oil tablets are assisted in chronic pain and symptoms of anxiety, and mention assistance with sleeplessness and opioid use as well. All in all, buyers on amazon have experienced excellent satisfaction in results following regular use.
Some additional positive news happened in June 2018, the Food and Drug Administration approved the first CBD-derived drug — Epidiolex, which contains purified CBD — to treat certain childhood seizure syndromes. Very promising findings and many are interested in long term effects. It’s likely that CBD will be used to treat other medical conditions in the near future.
At the top of our ranking is Portland-based Lazarus Naturals, which has honed a reputation for high-quality, affordable CBD. Their consciously crafted CBD is sourced from organic, Oregon-grown hemp which the company controls from seed to sale. With low prices, a robust assistance program, free shipping, and a 30-day, no questions asked return policy, you really can’t go wrong with Lazarus Naturals.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).